Avoid or Use Alternate Drug. Coadministration of apalutamide, a robust CYP3A4 inducer, with medicines which can be CYP3A4 substrates can result in decreased exposure to those medications. Prevent or substitute One more drug for these medications when attainable. Assess for lack of therapeutic effect if medication needs to be https://gautamab975xgo3.wikilima.com/user